Treating AUB in Your Practice

Abnormal Uterine Bleeding (AUB) is common

Under-reported, under-treated and normalized

AUB in our communities

Women with AUB have poor health related quality of life, below the 25th percentile of that of the general population³.

The price she pays: Direct costs of AUB – $1 billion

The price we all pay: Indirect costs of AUB – $12 billion

AUB around the world

In an international online survey study of 6,179 women aged 18–55

How many women in your community are quietly dealing with the burden of AUB?

  • 36% had either been diagnosed with heavy menstrual bleeding (HMB) or thought their menstruation was heavier than average, a common symptom of AUB
  • 41% of these women believed there were no treatment options available for them
  • Menstrual flow outside of normal volume, duration, regularity, or frequency is considered abnormal uterine bleeding (AUB)
  • One-third of outpatient visits to the gynecologist are for AUB1
  • AUB accounts for more than 70% of all gynecologic consults in the perimenopausal and post-menopausal years

We are The Uterine Health Company

Minerva Surgical provides device-enabled solutions for AUB that are uterus-sparing, minimally invasive, safe and effective.

In 2020, Minerva Surgical acquired three additional devices for the treatment of AUB, creating a complete, best-in-class intrauterine care kit.

We’re here to help optimize the delivery of care to those suffering from AUB by offering on-demand support to assist your team.

For support contact us at:

  • Transitioning treatments to the office setting
  • In-office hysteroscopy supplies checklist
  • In-office polypectomy supplies checklist
  • In-office endometrial ablation supplies checklist
  • Pain management & anesthesia guidelines brochure*
  • Reimbursement information
  • VAC presentation support
  • Patient outreach programs

This resource is not available to order